103,027 research outputs found
Introduction. Musique et littérature: un dialogue (im)possible
No full textOver the years the relationship between literature and music has been questioned, exceeded and crossed in different directions. This phenomenon demonstrates a continuous exchange between the two fields, characterized by a reciprocity which generates meaning. This inter artes exchange is the starting point of the present issue of RILUNE – Review of European Literatures, which aims to investigate the relationship between literature and music in European literatures, from a comparative and interdisciplinary approach, aiming to contribute to the contemporary cultural debate on the topic. We are interested in the different possibilities of analysis which the comparison and the combination of literature and music offer. The contributions in this volume are organised in three parts : (I) Music in the text : the inner sound of literature ; (II) Music written and described : musical thematisation in literature ; (III) New frontiers of transmediality and literary acoustics.Au fil des années les rapports entre musique et littérature ont été mis en cause, dépassés et traversés en plusieurs directions. Cela témoigne d’un perpétuel échange entre les deux domaines, caractérisé par une réciprocité productrice de sens. C’est ce rapport inter artes le point de départ du numéro 15 de RILUNE – Revue des littératures européennes, qui se propose d’enquêter les relations entre littérature et musique dans les littératures européennes selon une approche comparée et interdisciplinaire, caractérisée par plusieurs points d’observation et visant à s’inscrire dans le vif débat contemporain. Notre intérêt se porte sur les différentes possibilités d’analyse offertes par la comparaison et par le mélange entre la littérature et la musique. Les contributions de ce volume s’organisent autour de trois volets : (I) La musique en filigrane dans le texte : la sonorité interne de la littérature ; (II) La musique (d)écrite : thématisassions musicales en littérature ; (III) Nouvelles frontières de la transmédialité et de l’acoustique littéraire
Erratum to Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells (Pituitary, (2015),10.1007/s11102-015-0669-y)
No full textDue to administrative changes involving the Institution, where the coauthors Matteo Zoli, Diego Mazzatenta, and Giorgio Frank are affiliated with, the authors have become part of the Institute of Neurological Sciences (of Bologna)
Prefazione
No full textprefazione al volume "La riforma dello sport: contributi di diritto ed economia dello sport" a cura di G. Martinelli e M. Rogolin
S.E.M. study II. Protective effect of ranitidine against gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs
No full textThe effect of Ranitidine on the gastric and duodenal lesions induced by Aspirin or Piroxicam was studied by scanning electron microscopy (SEM). Twelve patients were entered into the study. The first group consisted of 6 patients with normal basic morphology, of which 3 were treated with 1.5 g of Aspirin and Ranitidine 300 mg/day, and 3 with 20 mg of Piroxicam and Ranitidine 300 mg/day, for one month. The second group was composed of 6 rheumatic patients, 3 of which took 1.5 g of Aspirin and the other 3 received 20 mg of Piroxicam per day for at least four months. Ranitidine (300 mg/day) was then administered concomitantly for one month to all these 6 patients. Overall, Ranitidine appeared to have a positive effect in preventing the development of gastroduodenal lesions induced by these anti-inflammatory drugs in the first group of patients. No differences were observed in the ability of Ranitidine to promote the healing of lesions induced by chronic treatment. Ranitidine, however, appeared to be more effective in preventing lesions induced by Aspirin rather than those induced by Piroxicam
La privatizzazione dei rapporti di lavoro pubblico a dieci anni dalla riforma: oscillazioni e assestamenti
No full text
S.E.M. study I: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man
No full textA scanning electron microscopy (SEM) study was performed on the gastric and duodenal mucosa of 14 patients treated with Aspirin or Piroxicam. Six patients with normal mucosal morphology were treated with either 1.5 g/day of Aspirin (3 patients) or 20 mg/day of Piroxicam (3 patients) for one month. In addition, 8 rheumatic patients were treated with a similar dose of Aspirin (4 patients) or Piroxicam (4 patients) for at least 4 months. SEM was used to evaluate the following parameters: mucosal structure, cellular exfoliation and anisocytosis, alteration of the microvilli (blebs). The mucosa showed various aspects of alterations ranging from minimal changes (microvillar alteration) to a completely subverted structure both in the stomach and in the duodenum. Mucosal changes, both on the edge of the macroscopic lesions and at a distance from these, were visible with SEM even when endoscopy was normal. Piroxicam appeared slightly less damaging than Aspirin, and no difference was observed between short-term and long-term treated patients, either with Aspirin or with Piroxicam
Homocysteine and cardiovascular risk in patients with intestinal transplantation.
No full textPLASMA TOTAL HOMOCYSTEINE (HCY) AS ADDITIONAL CARDIOVASCULAR RISK FACTOR IN PATIENTS WITH INTESTINAL TRANSPLANTATION
G Bianchi, E Pompignoli, A Lauro, G Passerini, R Chianese, A Pinna, M Zoli
Dipartimento di Medicina Interna, Cardioangiologia, Epatologia and Centro Trapianti, Università di Bologna
Transplanted patients show an increased rate of cardiovascular events, probably due to metabolic changes induced by immunosuppressive therapy. Among cardiovascular risk factors, high plasma homocysteine (HiHCY) has an indepedent role. No data are available about HiHCY prevalence in subjects with intestinal transplant (ITX) as effect of immunosuppressive drugs.
21 subjects, ageing 24 to 57, with ITX dating 6 months or more (median 29 months; range 6-69) were tested in 79 determinations. All patients received Tacrolimus (FK) as major immunosuppressive agent. Total Hcy was assayed on chromatography. Routine laboratory data, history of diabetes, hypertension, dyslipidemia, overweight and cardiovascular events, occurred over 6 months from ITX, were recorded. Additional events were recorded during the study period.
ITX subjects showed increased Hcy levels (median 19 mmol/L, range 8.6 – 80.6). 75% of ITX patients had Hcy >15 μmol/L. The same prevalence was observed for patients with mild kidney failure (creatinine levels above 1.7 mg/dl). Patients with normal and increased creatinine did not differ significantly for HCY or prevalence of HiHCY, and no relation was present between the two variables. Total homocysteine plasma levels were related to tacrolimus serum levels (R = 0.305, P < 0.01).
One heart ischemic problem was observed in a patient with severe kidney failure; two patients had problems in abdominal and/or peripheral venous districts, with HiHCY and some signs of the metabolic syndrome. HiHCY is frequently found in ITX patients. Its role in the genesis of cardiovascular events and the usefulness of a HiHCY lowering therapy remains to verify
Use of pyridoxine-alpha-ketoglutarate (PAK) in hepatic encephalopathy
No full textPyridoxine-alpha-ketoglutarate (PAK) was administered to patients with high blood ammonia levels and with clinical signs of hepatic encephalopathy (HE). Plasma concentrations of ammonia decreased and clinical symptomatology improved. The activity of PAK was greater than that of lactulose in lowering blood ammonia levels but not significantly different in its relief of neuropsychic symptoms
- …
